- Home
- ILAG vs MIRA Comparison
ILAG vs MIRA Comparison
Compare ILAG & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILAG
- MIRA
- Stock Information
- Founded
- ILAG 1981
- MIRA 2020
- Country
- ILAG Hong Kong
- MIRA United States
- Employees
- ILAG N/A
- MIRA N/A
- Industry
- ILAG Office Equipment/Supplies/Services
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- ILAG Consumer Discretionary
- MIRA Health Care
- Exchange
- ILAG Nasdaq
- MIRA Nasdaq
- Market Cap
- ILAG 9.4M
- MIRA 19.5M
- IPO Year
- ILAG 2022
- MIRA 2023
- Fundamental
- Price
- ILAG $0.51
- MIRA $1.30
- Analyst Decision
- ILAG
- MIRA Strong Buy
- Analyst Count
- ILAG 0
- MIRA 2
- Target Price
- ILAG N/A
- MIRA $14.00
- AVG Volume (30 Days)
- ILAG 427.2K
- MIRA 2.4M
- Earning Date
- ILAG 07-22-2025
- MIRA 08-12-2025
- Dividend Yield
- ILAG N/A
- MIRA N/A
- EPS Growth
- ILAG N/A
- MIRA N/A
- EPS
- ILAG N/A
- MIRA N/A
- Revenue
- ILAG $7,506,551.00
- MIRA N/A
- Revenue This Year
- ILAG N/A
- MIRA N/A
- Revenue Next Year
- ILAG N/A
- MIRA N/A
- P/E Ratio
- ILAG N/A
- MIRA N/A
- Revenue Growth
- ILAG 16.50
- MIRA N/A
- 52 Week Low
- ILAG $0.34
- MIRA $0.57
- 52 Week High
- ILAG $1.35
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- ILAG 51.90
- MIRA 56.46
- Support Level
- ILAG $0.49
- MIRA $1.07
- Resistance Level
- ILAG $0.52
- MIRA $1.39
- Average True Range (ATR)
- ILAG 0.05
- MIRA 0.10
- MACD
- ILAG -0.01
- MIRA 0.00
- Stochastic Oscillator
- ILAG 41.32
- MIRA 70.78
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.